| Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status. | |
| | |
MedLine Citation:
|
PMID: 20932553 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
INTRODUCTION: Peripheral arterial disease (PAD) and type 2 diabetes mellitus (DM) are both associated with excessive vascular calcification and elevated levels of inflammatory markers IL-6 and hsCRP. The recently identified Osteoprotegerin(OPG)/RANKL/TRAIL pathway has been implicated in vascular calcification, but data on levels in PAD and effect of co-existent DM are lacking. MATERIALS AND METHODS: 4 groups of patients were recruited - 26 with PAD and DM, 35 with DM alone, 22 with PAD alone, and 21 healthy individuals. Serum OPG, RANKL, TRAIL, hsCRP and IL-6 were measured using commercial ELISA assays. Presence and severity of PAD was defined using ankle brachial index (ABI). RESULTS: Serum OPG (7.4±0.3 vs.5.8±0.2 pmol/l, p<0.0001), TRAIL (95.5±5.2 ng/ml vs. 76.2±4.4 ng/ml, p=0.006), hsCRP (2.6±0.3 vs. 1.8±0.3 mg/l, p=0.048), and IL-6 (4.1±0.4 vs. 2.9±0.4 pg/ml, p=0.06) were higher in patients with PAD. There was no difference in RANKL. Only OPG was significantly higher in PAD and DM (7.2±0.3 pmol/l) and PAD alone (7.7±0.4 pmol/l) compared to DM only (5.8±0.3 pmol/l) and healthy controls (5.6±0.4 pmol/l), p<0.01, but OPG was no higher in those with DM plus PAD versus those with PAD alone (p<0.3). Only OPG was associated with PAD severity, correlating negatively with ABI (r=-0.26, p=0.03), independent of age, gender, glycaemic status, hsCRP and IL-6. CONCLUSIONS: PAD is associated with higher serum OPG, regardless of the co-existence of DM. This finding, in addition to its correlation with severity of PAD, suggests that OPG may be a novel marker for the presence and severity of PAD, possibly by reflecting the degree of underlying vascular calcification. |
| | |
Authors:
|
Eoin P O'Sullivan; David T Ashley; Colin Davenport; James Kelly; Niamh Devlin; Rachel Crowley; Austin L Leahy; Cathal J Kelly; Amar Agha; Christopher J Thompson; Donal J O'Gorman; Patricia Fitzgerald; Diarmuid Smith |
Related Documents
:
|
12375803 - C-reactive protein as a marker for active coronary artery disease in patients with ches... 20644113 - Down-regulation of hepcidin resulting from long-term treatment with an anti-il-6 recept... 19142633 - Fdg-pet changes in brain glucose metabolism from normal cognition to pathologically ver... |
Publication Detail:
|
Type: Journal Article Date: 2010-10-06 |
Journal Detail:
|
Title: Thrombosis research Volume: 126 ISSN: 1879-2472 ISO Abbreviation: Thromb. Res. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-12-03 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0326377 Medline TA: Thromb Res Country: United States |
Other Details:
|
Languages: eng Pagination: e423-7 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Department of Diabetes, Royal College of Surgeons in Ireland Medical School, Beaumont Hospital, and Centre for Preventive Medicine, School of Health and Human Performance, Dublin City University, Dublin 9, Ireland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluation of the noncovalent binding interactions between polycyclic aromatic hydrocarbon metabolit...
Next Document: Involvement of heparanase in vaginal and cesarean section deliveries.